Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 13NIH 4NETWORK 2

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Lymphoma 43Breast Neoplasms 37Lymphoma, Large B-Cell, Diffuse 29Sarcoma 20Lymphoma, Non-Hodgkin 17Burkitt Lymphoma 16Neuroblastoma 15Leukemia 13HIV Infections 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Hodgkin Disease 11Acquired Immunodeficiency Syndrome 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Ovarian Neoplasms 9Multiple Myeloma 9Carcinoma, Hepatocellular 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Follicular 8Liver Neoplasms 8Liposarcoma 7Breast Neoplasms, Male 7Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Anaplastic 6Fallopian Tube Neoplasms 6Sarcoma, Kaposi 5Neoplasms, Plasma Cell 5Lymphoma, B-Cell 5Lung Neoplasms 5Histiocytoma, Malignant Fibrous 5Fibrosarcoma 5

Interventions

Cyclophosphamide 10Docetaxel 6Trastuzumab 5Radiotherapy 5Tamoxifen 4Neoadjuvant Therapy 4Filgrastim 4Doxorubicin 4tipifarnib 3Peripheral Blood Stem Cell Transplantation 3Epirubicin 3Thiotepa 2Radiation 2Paclitaxel 2Fluorouracil 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Bevacizumab 2pegfilgrastim 1olaparib 1cediranib 1aldesleukin 1Therapeutics 1Taxes 1Specimen Handling 1Razoxane 1Methotrexate 1Mesna 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NIH × Inflammatory Breast Neoplasms × Doxorubicin × Clear all
NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
396 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡